Literature DB >> 10959066

Iaterogenic injuries during retrograde delivery of cardioplegia.

T K Kaul1, B L Fields, C R Jones.   

Abstract

During last eight years, retrograde delivery of cardioplegia was used on a regular basis, utilizing a DLP INC (Grand Rapids, MI) or a Research Medical INC (Salt Lake City UT) delivery systems, in almost an equal number of patients. This method resulted in a high pressure rupture, or perforation of the coronary sinus, its radicals or the right ventricle (RV) in 0.06% (5/7886) of patients. Intraoperative diagnosis of these injuries were confirmed on abnormal haemodynamic tracings and trans oesophageal echocardiography (TOE), and appearance of cardiac contusion or leakage of cardioplegia. A low incidence of these iaterogenic injuries may be attributed to: (1) a regular use of this method and (2) use of TOE guided manipulations in select high risk and reoperative patients. Repair of these injuries, as described, resulted in salvage of 4/5 (80%) patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10959066     DOI: 10.1016/s0967-2109(00)00029-6

Source DB:  PubMed          Journal:  Cardiovasc Surg        ISSN: 0967-2109


  3 in total

1.  Late Iatrogenic Coronary Sinus Hematoma During Cardiac Surgery.

Authors:  Alessandro Fiocco; Martina Dini; Antonio Campanella; Giosué Falcetta; Clemente Pascarella; Filippo Cademartiri; Andrea Colli
Journal:  JACC Case Rep       Date:  2022-06-01

Review 2.  Retrograde Coronary Venous Infusion as a Delivery Strategy in Regenerative Cardiac Therapy: an Overview of Preclinical and Clinical Data.

Authors:  Wouter A Gathier; Dirk Jan van Ginkel; Mira van der Naald; Frebus J van Slochteren; Pieter A Doevendans; Steven A J Chamuleau
Journal:  J Cardiovasc Transl Res       Date:  2018-02-01       Impact factor: 4.132

3.  Lower retention after retrograde coronary venous infusion compared with intracoronary infusion of mesenchymal stromal cells in the infarcted porcine myocardium.

Authors:  Wouter A Gathier; Mira van der Naald; Bas R van Klarenbosch; Anton E Tuinenburg; John Lm Bemelmans; Klaus Neef; Joost Pg Sluijter; Frebus J van Slochteren; Pieter A Doevendans; Steven Aj Chamuleau
Journal:  BMJ Open Sci       Date:  2019-01-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.